Abstract
Cognitive dysfunction is an adverse effect of antineoplastic agents. The number of cancer patient survivors is increasing nowadays, but along with this achievement, the side effects of chemotherapy are also develo** simultaneously. One of the adverse effects, CICI (chemotherapy-induced cognitive impairment), also known as “chemofog” or “chemobrain,” brings huge challenges in front of cancer survivors after successful chemotherapy. Around 75% of patients experience CICI during the treatment and another 35% experience it after the treatment. Patients have symptoms such as impairments in visual-verbal memory, awareness, working ability, concentration, attention, executive functions, fatigue, and behavioral dysfunctions that adversely affect the quality of life of cancer survivors. Apart from this, clinical reports demonstrated associated mood disorders with vascular complications and seizures in some cases. Many mechanistic candidates have been studied, including disruption of the blood-brain barrier (BBB), suppressed hippocampal neurogenesis, neuronal growth, disruption, cell death, white matter abnormalities, inflammatory response, increased oxidative stress, and brain blood flow impairment. Oxidative stress is considered a vital mechanism since over 50% of FDA-approved anticancer drugs can generate reactive oxygen species (ROS) or reactive nitrogen species (RNS), which lead to neuronal death. Chemobrain pathology has been hypothesized as a multifactorial process causing cognitive dysfunction via the interaction of several mechanisms, as it is not a single mechanism that can be considered the reason for develo** chemobrain. Here we will discuss in an overview some of CICI’s most possible underlying mechanisms.
This is a preview of subscription content, log in via an institution to check access.
References
Abraham J, Haut MW, Moran MT, Filburn S, Lemiuex S, Kuwabara H (2008) Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging. Clin Breast Cancer 8(1):88–91. https://doi.org/10.3816/CBC.2008.n.007
Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7(3):192–201. https://doi.org/10.1038/nrc2073
Bagnall-Moreau C, Chaudhry S, Salas-Ramirez K, Ahles T, Hubbard K (2019) Chemotherapy-induced cognitive impairment is associated with increased inflammation and oxidative damage in the hippocampus. Mol Neurobiol 56(10):7159–7172. https://doi.org/10.1007/s12035-019-1589-z
Bansal N, Amdani SM, Hutchins KK, Lipshultz SE (2018) Cardiovascular disease in survivors of childhood cancer. Curr Opin Pediatr 30(5):628–638. https://doi.org/10.1097/MOP.0000000000000675
Bruno J, Hosseini SM, Kesler S (2012) Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors. Neurobiol Dis 48(3):329–338. https://doi.org/10.1016/j.nbd.2012.07.009
Butterfield DA (2014) The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer’s disease and chemotherapy induced cognitive impairment. Free Radic Biol Med 74:157–174. https://doi.org/10.1016/j.freeradbiomed.2014.06.006
Callaghan CK, O’Mara SM (2015) Long-term cognitive dysfunction in the rat following docetaxel treatment is ameliorated by the phosphodiesterase-4 inhibitor, rolipram. Behav Brain Res 290:84–89. https://doi.org/10.1016/j.bbr.2015.04.044
Chen JK, Taipale J, Cooper MK, Beachy PA (2002) Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes dev 16(21):2743–8. https://doi.org/10.1101/gad.1025302.
Cheung YT, Ng T, Shwe M, Ho HK, Foo KM, Cham MT, Lee JA, Fan G, Tan YP, Yong WS, Madhukumar P, Loo SK, Ang SF, Wong M, Chay WY, Ooi WS, Dent RA, Yap YS, Ng R, Chan A (2015) Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Ann Oncol 26(7):1446–1451. https://doi.org/10.1093/annonc/mdv206
Christie LA, Acharya MM, Parihar VK, Nguyen A, Martirosian V, Limoli CL (2012) Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clin Cancer Res 18(7):1954–1965. https://doi.org/10.1158/1078-0432.CCR-11-2000
Costantini D (2019) Understanding diversity in oxidative status and oxidative stress: the opportunities and challenges ahead. J Exp Biol 222(Pt 13):jeb194688. https://doi.org/10.1242/jeb.194688
Cruzado JA, López-Santiago S, Martínez-Marín V, José-Moreno G, Custodio AB, Feliu J (2014) Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients. Support Care Cancer 22(7):1815–1823. https://doi.org/10.1007/s00520-014-2147-x
de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FS, Schagen SB (2012) Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp 33(12):2971–2983. https://doi.org/10.1002/hbm.21422
Deprez S, Amant F, Yigit R, Porke K, Verhoeven J, Van den Stock J, Smeets A, Christiaens MR, Leemans A, Van Hecke W, Vandenberghe J, Vandenbulcke M, Sunaert S (2011) Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp 32(3):480–493. https://doi.org/10.1002/hbm.21033
Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M (2006) CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 5(7):22. https://doi.org/10.1186/jbiol50
El-Agamy SE, Abdel-Aziz AK, Wahdan S, Esmat A, Azab SS (2018) Astaxanthin ameliorates doxorubicin-induced cognitive impairment (chemobrain) in experimental rat model: impact on oxidative, inflammatory, and apoptotic machineries. Mol Neurobiol 55(7):5727–5740. https://doi.org/10.1007/s12035-017-0797-7
Erickson KI, Banducci SE, Weinstein AM, MacDonald III AW, Ferrell RE, Halder I, Flory JD, Manuck SB (2013) The brain-derived neurotrophic factor Val66Met polymorphism moderates an effect of physical activity on working memory performance. Psychol Sci 24(9):1770–9. https://doi.org/10.1177/0956797613480367
Fahim A, Rehman Z, Bhatti MF, Virk N, Ali A, Rashid A, Paracha RZ (2019) The route to ‘Chemobrain’ – computational probing of neuronal LTP pathway. Sci Rep 9(1):9630. https://doi.org/10.1038/s41598-019-45883-9
Fardell JE, Vardy J, Shah JD, Johnston IN (2012) Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity. Psychopharmacology 220(1):183–193. https://doi.org/10.1007/s00213-011-2466-2
Fardell JE, Vardy J, Johnston IN (2013) The short and long term effects of docetaxel chemotherapy on rodent object recognition and spatial reference memory. Life Sci 93(17):596–604. https://doi.org/10.1016/j.lfs.2013.05.006
Fardell JE, Zhang J, De Souza R, Vardy J, Johnston I, Allen C, Henderson J, Piquette-Miller M (2014) The impact of sustained and intermittent docetaxel chemotherapy regimens on cognition and neural morphology in healthy mice. Psychopharmacology 231(5):841–852. https://doi.org/10.1007/s00213-013-3301-8
Foley JJ, Raffa RB, Walker EA (2008) Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory. Psychopharmacology 199(4):527–538. https://doi.org/10.1007/s00213-008-1175-y
Franco R, Navarro G, Martínez-Pinilla E (2019) Antioxidant defense mechanisms in erythrocytes and in the central nervous system. Antioxidants (Basel) 8(2):46. https://doi.org/10.3390/antiox8020046
Gaman AM, Uzoni A, Popa-Wagner A, Andrei A, Petcu EB (2016) The role of oxidative stress in etiopathogenesis of chemotherapy induced cognitive impairment (CICI)-“Chemobrain”. Aging Dis 7(3):307–317. https://doi.org/10.14336/AD.2015.1022
Groven N, Fors EA, Iversen VC, White LR, Reitan SK (2018) Association between cytokines and psychiatric symptoms in chronic fatigue syndrome and healthy controls. Nord J Psychiatry 72(8):556–560. https://doi.org/10.1080/08039488.2018.1493747
Han R, Yang YM, Dietrich J, Luebke A, Mayer-Pröschel M, Noble M (2008) Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol 7(4):12. https://doi.org/10.1186/jbiol69
Hayslip J, Dressler EV, Weiss H, Taylor TJ, Chambers M, Noel T, Miriyala S, Keeney JT, Ren X, Sultana R, Vore M, Butterfield DA, St Clair D, Moscow JA (2015) Plasma TNF-α and soluble TNF receptor levels after doxorubicin with or without co-administration of mesna – a randomized, cross-over clinical study. PLoS One 10(4):e0124988. https://doi.org/10.1371/journal.pone.0124988
Henderson FM, Cross AJ, Baraniak AR (2019) ‘A new normal with chemobrain’: experiences of the impact of chemotherapy-related cognitive deficits in long-term breast cancer survivors. Health Psychol Open 6(1):2055102919832234. https://doi.org/10.1177/2055102919832234
Huehnchen P, Boehmerle W, Springer A, Freyer D, Endres M (2017) A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL/6 mice. Transl Psychiatry 7(8):e1185. https://doi.org/10.1038/tp.2017.149
Inagaki M, Yoshikawa E, Matsuoka Y, Sugawara Y, Nakano T, Akechi T, Wada N, Imoto S, Murakami K, Uchitomi Y (2007) Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 109(1):146–156. https://doi.org/10.1002/cncr.22368
Ji LL, Yeo D (2021) Oxidative stress: an evolving definition. Fac Rev 10:13. https://doi.org/10.12703/r/10-13
Jiang T, Yu JT, Zhu XC, Tan MS, Wang HF, Cao L, Zhang QQ, Shi JQ, Gao L, Qin H, Zhang YD, Tan L (2014) Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in cellular and animal models of Alzheimer’s disease. Pharmacol Res 81:54–63. https://doi.org/10.1016/j.phrs.2014.02.008
Jung MS, Visovatti M (2017) Post-treatment cognitive dysfunction in women treated with thyroidectomy for papillary thyroid carcinoma. Support Care Cancer 25(3):915–923. https://doi.org/10.1007/s00520-016-3481-y
Keeney JTR, Ren X, Warrier G, Noel T, Powell DK, Brelsfoard JM, Sultana R, Saatman KE, Clair DKS, Butterfield DA (2018) Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”). Oncotarget 9(54):30324–30339. https://doi.org/10.18632/oncotarget.25718
Konat GW, Kraszpulski M, James I, Zhang HT, Abraham J (2008) Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats. Metab Brain Dis 23(3):325–333. https://doi.org/10.1007/s11011-008-9100-y
Li Y, Vijayanathan V, Gulinello ME, Cole PD (2010) Systemic methotrexate induces spatial memory deficits and depletes cerebrospinal fluid folate in rats. Pharmacol Biochem Behav 94(3):454–463. https://doi.org/10.1016/j.pbb.2009.10.008
Macleod JE, DeLeo JA, Hickey WF, Ahles TA, Saykin AJ, Bucci DJ (2007) Cancer chemotherapy impairs contextual but not cue-specific fear memory. Behav Brain Res 181(1):168–172. https://doi.org/10.1016/j.bbr.2007.04.003
McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ (2012) Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol 30(20):2500–2508. https://doi.org/10.1200/JCO.2011.38.5674
Merzoug S, Toumi ML, Tahraoui A (2014) Quercetin mitigates Adriamycin-induced anxiety- and depression-like behaviors, immune dysfunction, and brain oxidative stress in rats. Naunyn Schmiedeberg’s Arch Pharmacol 387(10):921–933. https://doi.org/10.1007/s00210-014-1008-y
Mondie CM, Vandergrift KA, Wilson CL, Gulinello ME, Weber ET (2010) The chemotherapy agent, thioTEPA, yields long-term impairment of hippocampal cell proliferation and memory deficits but not depression-related behaviors in mice. Behav Brain Res 209(1):66–72. https://doi.org/10.1016/j.bbr.2010.01.016
Monje M, Dietrich J (2012) Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behav Brain Res 227(2):376–379. https://doi.org/10.1016/j.bbr.2011.05.012. Epub 2011 May 23. PMID: 21621557; PMCID: PMC3221863
Mounier NM, Abdel-Maged AE, Wahdan SA, Gad AM, Azab SS (2020) Chemotherapy-induced cognitive impairment (CICI): an overview of etiology and pathogenesis. Life Sci 258:118071. https://doi.org/10.1016/j.lfs.2020.118071
Mustafa S, Walker A, Bennett G, Wigmore PM (2008) 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus. Eur J Neurosci 28(2):323–330. https://doi.org/10.1111/j.1460-9568.2008.06325.x
Reiriz AB, Reolon GK, Preissler T, Rosado JO, Henriques JA, Roesler R, Schwartsmann G (2006) Cancer chemotherapy and cognitive function in rodent models: memory impairment induced by cyclophosphamide in mice. Clin Cancer Res 12(16):5000; author reply 5000-1. https://doi.org/10.1158/1078-0432.CCR-06-0138
Ren X, Boriero D, Chaiswing L, Bondada S, St Clair DK, Butterfield DA (2019) Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors. Biochim Biophys Acta Mol basis Dis 1865(6):1088–1097. https://doi.org/10.1016/j.bbadis.2019.02.007. Epub 2019 Feb 10
Rieben C, Segna D, da Costa BR, Collet TH, Chaker L, Aubert CE, Baumgartner C, Almeida OP, Hogervorst E, Trompet S, Masaki K, Mooijaart SP, Gussekloo J, Peeters RP, Bauer DC, Aujesky D, Rodondi N (2016) Subclinical thyroid dysfunction and the risk of cognitive decline: a meta-analysis of prospective cohort studies. J Clin Endocrinol Metab 101(12):4945–4954. https://doi.org/10.1210/jc.2016-2129
Rizzo FR, Musella A, De Vito F, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Mandolesi G, Centonze D, Gentile A (2018) Tumor necrosis factor and interleukin-1β modulate synaptic plasticity during neuroinflammation. Neural Plast 2018:8430123. https://doi.org/10.1155/2018/8430123
Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM (2018) Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer 18(7):452–464. https://doi.org/10.1038/s41568-018-0005-8
Russo E, Leo A, Crupi R, Aiello R, Lippiello P, Spiga R, Chimirri S, Citraro R, Cuzzocrea S, Constanti A, De Sarro G (2016) Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression. J Psychiatr Res 78:1–10. https://doi.org/10.1016/j.jpsychires.2016.03.008
Salim S (2017) Oxidative stress and the central nervous system. J Pharmacol Exp Ther 360(1):201–205. https://doi.org/10.1124/jpet.116.237503
Seigers R, Schagen SB, Beerling W, Boogerd W, van Tellingen O, van Dam FS, Koolhaas JM, Buwalda B (2008) Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res 186(2):168–175. https://doi.org/10.1016/j.bbr.2007.08.004
Seigers R, Schagen SB, Coppens CM, van der Most PJ, van Dam FS, Koolhaas JM, Buwalda B (2009) Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats. Behav Brain Res 201(2):279–284. https://doi.org/10.1016/j.bbr.2009.02.025
Seigers R, Timmermans J, van der Horn HJ, de Vries EF, Dierckx RA, Visser L, Schagen SB, van Dam FS, Koolhaas JM, Buwalda B (2010) Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release. Behav Brain Res 207(2):265–272. https://doi.org/10.1016/j.bbr.2009.10.009
Seigers R, Schagen SB, Van Tellingen O, Dietrich J (2013) Chemotherapy-related cognitive dysfunction: current animal studies and future directions. Brain Imaging Behav 7(4):453–459. https://doi.org/10.1007/s11682-013-9250-3
Shi DD, Huang YH, Lai CSW, Dong CM, Ho LC, Wu EX, Li Q, Wang XM, Chung SK, Sham PC, Zhang ZJ (2019) Chemotherapy-induced cognitive impairment is associated with cytokine dysregulation and disruptions in neuroplasticity. Mol Neurobiol 56(3):2234–2243. https://doi.org/10.1007/s12035-018-1224-4
Silverman DH, Dy CJ, Castellon SA, Lai J, Pio BS, Abraham L, Waddell K, Petersen L, Phelps ME, Ganz PA (2007) Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy. Breast Cancer Res Treat 103(3):303–311. https://doi.org/10.1007/s10549-006-9380-z
Singh A, Kukreti R, Saso L, Kukreti S (2019) Oxidative stress: a key modulator in neurodegenerative diseases. Molecules 24(8):1583. https://doi.org/10.3390/molecules24081583
Siracusa R, Paterniti I, Cordaro M, Crupi R, Bruschetta G, Campolo M, Cuzzocrea S, Esposito E (2018) Neuroprotective effects of Temsirolimus in animal models of Parkinson’s disease. Mol Neurobiol 55(3):2403–2419. https://doi.org/10.1007/s12035-017-0496-4
Smith AE, Slivicki RA, Hohmann AG, Crystal JD (2017) The chemotherapeutic agent paclitaxel selectively impairs learning while sparing source memory and spatial memory. Behav Brain Res 320:48–57. https://doi.org/10.1016/j.bbr.2016.11.042
Tangpong J, Cole MP, Sultana R, Estus S, Vore M, St Clair W, Ratanachaiyavong S, St Clair DK, Butterfield DA (2007) Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain. J Neurochem 100(1):191–201. https://doi.org/10.1111/j.1471-4159.2006.04179.x
Vardy JL, Dhillon HM, Pond GR, Rourke SB, Bekele T, Renton C, Dodd A, Zhang H, Beale P, Clarke S, Tannock IF (2015) Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: a prospective, longitudinal, controlled study. J Clin Oncol 33(34):4085–4092. https://doi.org/10.1200/JCO.2015.63.0905
Vaure C, Liu Y (2014) A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol 5:316. https://doi.org/10.3389/fimmu.2014.00316
Wardill HR, Gibson RJ, Van Sebille YZ, Secombe KR, Coller JK, White IA, Manavis J, Hutchinson MR, Staikopoulos V, Logan RM, Bowen JM (2016) Irinotecan-induced gastrointestinal dysfunction and pain are mediated by common TLR4-dependent mechanisms. Mol Cancer Ther 15(6):1376–1386. https://doi.org/10.1158/1535-7163.MCT-15-0990
Winocur G, Wojtowicz JM, Huang J, Tannock IF (2014) Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats. Psychopharmacology 231(11):2311–2320. https://doi.org/10.1007/s00213-013-3394-0
Winocur G, Becker S, Luu P, Rosenzweig S, Wojtowicz JM (2012) Adult hippocampal neurogenesis and memory interference. Behav Brain Res 227(2):464–9. https://doi.org/10.1016/j.bbr.2011.05.032
Winocur G, Wojtowicz JM, Merkley CM, Tannock IF (2016) Environmental enrichment protects against cognitive impairment following chemotherapy in an animal model. Behav Neurosci 130(4):428–436. https://doi.org/10.1037/bne0000155
Winocur G, Berman H, Nguyen M, Binns MA, Henkelman M, van Eede M, Piquette-Miller M, Sekeres MJ, Wojtowicz JM, Yu J, Zhang H, Tannock IF (2018) Neurobiological mechanisms of chemotherapy-induced cognitive impairment in a transgenic model of breast cancer. Neuroscience 369:51–65. https://doi.org/10.1016/j.neuroscience.2017.10.048
Wojtowicz JM, Askew ML, Winocur G (2008) The effects of running and of inhibiting adult neurogenesis on learning and memory in rats. Eur J Neurosci 27(6):1494–1502. https://doi.org/10.1111/j.1460-9568.2008.06128.x
Wu LM, Amidi A (2017) Cognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients. Curr Opin Support Palliat Care 11(1):38–45. https://doi.org/10.1097/SPC.0000000000000251
Yang M, Kim JS, Song MS, Kim SH, Kang SS, Bae CS, Kim JC, Wang H, Shin T, Moon C (2010) Cyclophosphamide impairs hippocampus-dependent learning and memory in adult mice: possible involvement of hippocampal neurogenesis in chemotherapy-induced memory deficits. Neurobiol Learn Mem 93(4):487–494. https://doi.org/10.1016/j.nlm.2010.01.006
Yang MT, Lin YC, Ho WH, Liu CL, Lee WT (2017) Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures. J Neuroinflammation 14(1):15. https://doi.org/10.1186/s12974-017-0797-6
Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, Chen Y, Zhang Y (2020) COVID-19: Immunopathogenesis and Immunotherapeutics. Signal Transduct Target Ther 5(1):128. https://doi.org/10.1038/s41392-020-00243-2
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2024 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Dahiya, M., Yadav, M., Sharma, P., Joon, P., Kumar, A. (2024). Potential Pathways for Chemotherapy-Induced Cognitive Decline. In: Sobti, R.C., Ganguly, N.K., Kumar, R. (eds) Handbook of Oncobiology: From Basic to Clinical Sciences. Springer, Singapore. https://doi.org/10.1007/978-981-99-6263-1_60
Download citation
DOI: https://doi.org/10.1007/978-981-99-6263-1_60
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-6262-4
Online ISBN: 978-981-99-6263-1
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences